Timothy J. Barberich Joins Verastem, Inc. (VSTM) Board Of Directors
3/11/2014 7:00:26 AM
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced the appointment of Timothy J. Barberich to its Board of Directors.
“Tim is an entrepreneur at heart who has become a very successful biopharmaceutical business leader,” said Christoph Westphal, M.D., Ph.D., Verastem Executive Chairman. “As the CEO and Chairman of Sepracor, he has been intimately involved in the development and commercialization of many successful products. We are very pleased to welcome him to Verastem’s Board.”
Help employers find you! Check out all the jobs and post your resume.
comments powered by